SGEN - Seagen

-

$undefined

N/A

(N/A)

Seagen NASDAQ:SGEN Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. On Dec. 14, 2023, Pfizer completed the acquisition of Seagen.

Location: | Website: www.seagen.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

0.00

Cash

148.3M

Avg Qtr Burn

N/A

Short % of Float

7.38%

Insider Ownership

0.81%

Institutional Own.

88.83%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date